Fady Ibraham Malik is VP at CYTOKINETICS INC (CYTK). They have made 46 open-market trades across 1 company since 2014, most recently 2026-10-06.
CIK 0001551778
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 46 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CYTK | 153,902 | $9.5M |
| RCKT | 52,862 | $115K |
| Total | $9.7M |
Shares reported on the most recent Form 4, priced at the 2026-10-06 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CYTK | SELL | 2026-10-06 | 2026-10-06 | $61.38 | $215K | +2.6% | — | — |
| CYTK | SELL | 2026-09-22 | 2026-09-22 | $68.29 | $239K | -2.4% | — | — |
| CYTK | SELL | 2026-09-08 | 2026-09-08 | $75.46 | $264K | -8.1% | -17.1% | — |
| CYTK | SELL | 2026-08-18 | 2026-08-18 | $75.82 | $265K | -6.6% | -9.5% | — |
| CYTK | SELL | 2026-07-21 | 2026-07-23 | $80.59 | $282K | -4.1% | -5.9% | — |
| CYTK | SELL | 2026-07-07 | 2026-07-07 | $86.62 | $303K | -6.1% | -4.4% | -26.5% |
| CYTK | SELL | 2026-06-23 | 2026-06-23 | $79.51 | $278K | +6.2% | +1.7% | -16.2% |
| CYTK | SELL | 2026-06-09 | 2026-06-09 | $67.98 | $238K | +13.4% | +23.3% | +7.9% |
| CYTK | SELL | 2026-05-19 | 2026-05-20 | $75.69 | $265K | -9.3% | +1.4% | -2.6% |
| CYTK | SELL | 2026-05-05 | 2026-05-05 | $77.37 | $271K | -3.1% | -7.6% | -2.3% |
| CYTK | SELL | 2026-04-21 | 2026-04-21 | $65.69 | $230K | -4.5% | +17.6% | +19.1% |
| CYTK | SELL | 2026-04-07 | 2026-04-08 | $65.11 | $293K | +0.7% | +17.1% | +30.4% |
| CYTK | SELL | 2026-03-17 | 2026-03-18 | $62.15 | $748K | +1.6% | +7.6% | +21.3% |
| CYTK | SELL | 2026-03-09 | 2026-03-10 | $60.72 | $177K | -3.2% | +1.3% | +6.5% |
| CYTK | SELL · 10b5-1 | 2025-12-16 | 2025-12-16 | $61.24 | $135K | -0.6% | +2.1% | -2.0% |
| CYTK | SELL · 10b5-1 | 2025-12-02 | 2025-12-02 | $63.89 | $141K | -0.5% | -3.1% | -3.5% |
| CYTK | SELL · 10b5-1 | 2025-11-18 | 2025-11-18 | $66.45 | $146K | +1.0% | -4.9% | +1.9% |
| CYTK | SELL | 2025-11-04 | 2025-11-04 | $59.55 | $273K | +12.0% | +12.1% | +9.8% |
| CYTK | SELL | 2025-10-21 | 2025-10-21 | $58.22 | $245K | +10.1% | +9.9% | +10.4% |
| CYTK | SELL · 10b5-1 | 2025-10-07 | 2025-10-07 | $60.56 | $121K | -3.8% | -0.7% | +0.9% |
| CYTK | SELL · 10b5-1 | 2025-09-23 | 2025-09-23 | $49.28 | $99K | +17.8% | +18.9% | +35.7% |
| CYTK | SELL · 10b5-1 | 2025-09-09 | 2025-09-10 | $51.29 | $103K | -7.5% | +15.1% | +18.1% |
| CYTK | SELL · 10b5-1 | 2025-08-19 | 2025-08-19 | $38.31 | $77K | -6.8% | +30.1% | +76.6% |
| CYTK | SELL · 10b5-1 | 2025-08-05 | 2025-08-05 | $36.34 | $73K | +8.1% | +39.0% | +67.8% |
| CYTK | SELL · 10b5-1 | 2025-07-22 | 2025-07-23 | $37.47 | $75K | -3.4% | +1.2% | +52.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.